These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27381360)

  • 21. Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
    Ku K; Pogue JM; Moshos J; Bheemreddy S; Wang Y; Bhargava A; Campbell M; Khandker N; Lephart PR; Chopra T; Hayakawa K; Martin ET; Abreu-Lanfranco O; Dhar S; Kaye KS; Marchaim D
    Am J Infect Control; 2012 Dec; 40(10):983-7. PubMed ID: 22440526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successful treatment of pan-resistant Acinetobacter baumannii infection of the lung with tigecycline: a report of one case].
    Shao BB; Feng HB
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Oct; 25(10):636. PubMed ID: 24119705
    [No Abstract]   [Full Text] [Related]  

  • 24. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis.
    Tutuncu EE; Kuscu F; Gurbuz Y; Ozturk B; Haykir A; Sencan I
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e224-6. PubMed ID: 19962335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary experience with tigecycline treatment for severe infection in children.
    Ye S; Zhang C; Lin S
    Eur J Pediatr; 2018 Oct; 177(10):1489-1496. PubMed ID: 30008076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure.
    Liou BH; Lee YT; Kuo SC; Liu PY; Fung CP
    Antimicrob Agents Chemother; 2015; 59(6):3637-40. PubMed ID: 25824230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
    Morfin-Otero R; Dowzicky MJ
    Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry.
    Curcio D; Fernández F; Cané A; Barcelona L; Stamboulian D
    Braz J Infect Dis; 2008 Jun; 12(3):198-201. PubMed ID: 18833403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    Housman ST; Hagihara M; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis.
    Mei H; Yang T; Wang J; Wang R; Cai Y
    J Antimicrob Chemother; 2019 Dec; 74(12):3423-3431. PubMed ID: 31377765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and microbiological efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal infections in a Turkish university hospital.
    Avkan-Oguz V; Yapar N; Alp-Cavus S; Demir Onder K; Aktas E; Gulay Z; Cakır N
    Int J Clin Pract; 2013 Jun; 67(6):505-11. PubMed ID: 23679904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
    Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
    Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of tigecycline in pediatric clinical practice.
    Mastrolia MV; Galli L; De Martino M; Chiappini E
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):605-612. PubMed ID: 28395551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp.
    Eser OK; Ergin A; Tunçkanat F; Hasçelik G
    New Microbiol; 2008 Oct; 31(4):535-42. PubMed ID: 19123310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution.
    Chemaly RF; Hanmod SS; Jiang Y; Rathod DB; Mulanovich V; Adachi JA; Rolston KV; Raad II; Hachem RY
    Medicine (Baltimore); 2009 Jul; 88(4):211-220. PubMed ID: 19593226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
    Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
    Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis.
    Xia G; Jiang R
    Medicine (Baltimore); 2020 Mar; 99(10):e19466. PubMed ID: 32150105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal tigecycline treatment in experimental Acinetobacter baumannii endophthalmitis.
    Horozoglu F; Metan G; Sever O; Percin D; Topal CS; Gonen T; Keskinbora KH; Topcu B; Yanyali A
    J Chemother; 2012 Apr; 24(2):101-6. PubMed ID: 22546766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tigecycline in the Treatment of Patients with Necrotizing Skin and Soft Tissue Infections Due to Multiresistant Bacteria.
    Eckmann C; Heizmann W; Bodmann KF; von Eiff C; Petrik C; Loeschmann PA
    Surg Infect (Larchmt); 2015 Oct; 16(5):618-25. PubMed ID: 26115414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.